Texas 2019 - 86th Regular

Texas House Bill HR1272

Caption

Encouraging greater awareness of Familial Hypercholesterolemia.

Impact

The bill urges the implementation of lipid panel screenings for children in the third and fourth grades during their annual health check-ups. This aligns with recommendations from prominent health organizations, aiming to ensure that cases of FH are identified early, thus mitigating health risks and preventing premature cardiovascular events. By promoting screenings, the bill could significantly alter preventive health practices in schools across Texas, potentially leading to earlier interventions and better health outcomes for affected individuals.

Summary

House Bill 1272 is a resolution aimed at raising awareness of Familial Hypercholesterolemia (FH), a genetic condition that leads to dangerously high levels of LDL cholesterol and significantly increases the risk of early cardiovascular diseases. The bill emphasizes the need for increased public knowledge about FH, stressing that without treatment, which often requires cholesterol-lowering medications, affected individuals may face severe health complications as early as childhood. The intent of the bill is to facilitate early diagnosis through education and preventive screenings.

Contention

One contention surrounding HR1272 is the potential financial implications for schools and health systems in implementing the proposed screening protocols. Opponents may argue about the budgetary constraints that additional health screenings could impose, while supporters maintain that the long-term healthcare savings from preventing heart-related diseases would outweigh initial costs. Advocates argue that with proper resources and support, the state can significantly enhance public health and reduce the incidence of untreated FH, ultimately benefiting society as a whole.

Companion Bills

No companion bills found.

Previously Filed As

TX HR435

Urging the Texas Department of State Health Services and the Texas Health and Human Services Commission to expand their comprehensive cardiovascular screening programs.

TX HR257

Recognizing March 2023 as Triple-Negative Breast Cancer Awareness Month.

TX SR325

Recognizing those who are working to raise awareness about colorectal cancer and Lynch syndrome.

TX SR527

Recognizing August 17, 2023, as Coats' Disease Awareness Day.

TX HR1529

Recognizing May 2023 as Mental Health Awareness Month.

TX HR1488

Recognizing May 2023 as ALS Awareness Month.

TX HR1213

Recognizing AADC Deficiency Awareness Day.

TX HR77

Recognizing February 22, 2023, as Hypertrophic Cardiomyopathy Awareness Day.

TX SR169

Recognizing the fourth Wednesday of February as Hypertrophic Cardiomyopathy Awareness Day in Texas.

TX SR488

Recognizing AADC (Aromatic L-Amino Acid Decarboxylase) Deficiency Awareness Day.

Similar Bills

No similar bills found.